Company Board of Directors
Yossi Vinitski, Chairman of the Board
Mr. Vinitski is an Executive V.P. at Challenge I and II and a member of the Funds Investment Committee. Mr. Vinitski lead the Challenge Fund investments in Storage Networking (Acquired by LSI Logic NYSE: LSI), PowerDsine, X-Technology (Acquired by Guidant NASDAQ: GDT) M-Systems, Voltaire (NASDAQ: VOLT) and Coppergate (Acquired by Sigma designs NASDAQ: SIGM). Prior to joining the Funds, Mr. Vinitski was a Senior Investment Manager of Yozma Management & Investment Ltd., an Israeli venture capital fund. Mr. Vinitski led Yozma investments in Commtouch (NASDAQ: CTCHC) and Security-7 (Acquired by Computer Associates, NASDAQ: CA). Prior to this, Mr. Vinitski gained significant operational experience as a software engineer for several publicly traded high tech companies. Mr. Vinitski is a member of the board of directors of ImageSat, Onset, Schema, EarlySense (Chairman), Proteologics (TASE). Vinitski was elected to serve in the Board of the Israel Venture Association for the 3rd terms. Mr. Vinitski holds a B.Sc., cum laude, in Mechanical Engineering and an MBA from Tel-Aviv University.
Ittai Harel
Ittai Harel is a veteran of the life sciences industry. He has fifteen years of experience in this field covering a wide range of activities, from basic business and technology development to corporate executive management, in areas such as pharmaceutical development, drug delivery, medical devices and diagnostics. Before joining Pitango, Ittai was Director of Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) where he was responsible for strategic planning, in-licensing and M&A activities. Prior to his period with Nektar, Ittai held various management positions at large companies both in Israel and in the U.S. including IDEXX Laboratories (NASDAQ: IDXX) and IDGene Pharmaceuticals.
Dr. Guy Shinar
Dr. Shinar is a scientist and medical device entrepreneur. He is the former president and CEO of X-Technologies Inc., an interventional cardiology company that was sold to Guidant Corp. in 2003. He serves on the board of Dune Medical Devices, an Apax Partners portfolio company. Guy holds a Ph. D. in physics from the Weizmann Institute of Science, as well as an MBA from INSEAD. He is a graduate of the IDF Talpiot Project.
Dr. Adina Makover
Dr. Makover has managed venture capital investments in the biotech/ medical devices field for the past six years, and joined ProSeed in 2006. Previously she held senior management positions in life sciences companies focusing on drugs, diagnostics and tissue engineering. Holding positions of CEO and board member, R&D, process development and production manager, Dr Makover had responsibility for both technology and business aspects. Dr. Makover holds a joint Ph.D degree in life sciences from Columbia University ( USA) and Weizmann Institute of Science, ( Israel) and did post- doctoral research at the Weizmann Institute in Israel. Dr. Makover also holds an MBA degree from Bar-Ilan University.
Adi Goldin
Mr. Adi Goldin joined Docor International Management in 2004. Prior to joining Docor, he served as a Director of Investments and Analysis at Inventech Venture Capital, a public company which is traded on the Tel Aviv Stock Exchange. Before working at Inventech, Mr. Goldin practiced law at Israeli, Blustein, Kogan & Co. In addition, he was part of the teaching staff of the MBA program run jointly by Tel Aviv University and Northwestern University`s Kellogg School of Management (Chicago, USA). Mr. Goldin participated in the International Marketing Program and the Global Consulting Program, a joint project of Pennsylvania University`s Wharton Business School and Tel Aviv University`s Business School. Mr. Goldin is an associate of the Israel Bar Association. He holds M.A. and B.A degrees in Economics, both with outstanding honors, and an LL.B in Law – all from Tel Aviv University.
Avner Halperin
Mr. Halperin is a veteran high tech executive. He has served in several senior management positions including CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and VP of Business Development at Lenslet. He also worked as the R&D Manager at Eldat and was the Department Head of an R&D unit in the IDF Intelligence corps, where he participated in the Talpiot Project. Mr. Halperin earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from the MIT Sloan Fellows Executive MBA Program.
|
